Advantage Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$20K Sell
198
-355
-64% -$33.7K 0.02% 531
2019
Q2
$51K Sell
553
-425
-43% -$40.4K 0.04% 342
2019
Q1
$92K Sell
978
-500
-34% -$43.7K 0.07% 246
2018
Q4
$95K Sell
1,478
-200
-12% -$14.8K 0.07% 246
2018
Q3
$150K Sell
1,678
-200
-11% -$17.7K 0.1% 199
2018
Q2
$149K Sell
1,878
-100
-5% -$8.3K 0.11% 163
2018
Q1
$176K Buy
1,978
+650
+49% +$62.4K 0.07% 173
2017
Q4
$139K Buy
1,328
+150
+13% +$16.9K 0.04% 219
2017
Q3
$172K Sell
1,178
-17
-1% -$2.32K 0.06% 188
2017
Q2
$155K Sell
1,195
-33
-3% -$4.04K 0.05% 188
2017
Q1
$153K Sell
1,228
-100
-8% -$12K 0.06% 171
2016
Q4
$154K Sell
1,328
-44
-3% -$4.9K 0.06% 166
2016
Q3
$143K Buy
1,372
+4
+0.3% +$433 0.05% 173
2016
Q2
$135K Buy
1,368
+50
+4% +$5.17K 0.06% 179
2016
Q1
$132K Sell
1,318
-262
-17% -$27K 0.06% 180
2015
Q4
$189K Hold
1,580
0.1% 139
2015
Q3
$171K Sell
1,580
-30
-2% -$3.72K 0.1% 138
2015
Q2
$186K Buy
1,610
+62
+4% +$7.09K 0.09% 146
2015
Q1
$178K Buy
1,548
+166
+12% +$19.8K 0.1% 152
2014
Q4
$155K Buy
+1,382
New +$146K 0.12% 146

Other funds holding CELG

Advantage Investment Management's CELG Position: Q3 2019 in Review

Advantage Investment Management reduced its Celgene Corp (CELG) stake by 64% in Q3 2019, selling an estimated $33.7K and leaving 198 shares worth $20K. The position accounts for 0.02% of the portfolio, ranked #531.

Advantage Investment Management first reported a position in CELG in Q4 2014 and has held it in 20 quarters since. The position peaked at $189K in Q4 2015. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Advantage Investment Management held 198 shares of Celgene Corp worth $20K as of Q3 2019.
  • Advantage Investment Management sold 355 Celgene Corp shares in Q3 2019, an estimated $33.7K.
  • Celgene Corp made up 0.02% of Advantage Investment Management's portfolio in Q3 2019, its #531 holding.
  • Advantage Investment Management first reported a position in Celgene Corp in Q4 2014 and has held it in 20 quarters since.
  • Advantage Investment Management's Celgene Corp position peaked at $189K in Q4 2015.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.